Human Genome Epidemiology Literature Finder
|
Records 1 - 1 (of 1 Records) |
| Query Trace: Neuroblastoma and NBL1[original query] |
|---|
| Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Jun JCO2100086. Bellini Angela, Pötschger Ulrike, Bernard Virginie, Lapouble Eve, Baulande Sylvain, Ambros Peter F, Auger Nathalie, Beiske Klaus, Bernkopf Marie, Betts David R, Bhalshankar Jaydutt, Bown Nick, de Preter Katleen, Clément Nathalie, Combaret Valérie, Font de Mora Jaime, George Sally L, Jiménez Irene, Jeison Marta, Marques Barbara, Martinsson Tommy, Mazzocco Katia, Morini Martina, Mühlethaler-Mottet Annick, Noguera Rosa, Pierron Gaelle, Rossing Maria, Taschner-Mandl Sabine, Van Roy Nadine, Vicha Ales, Chesler Louis, Balwierz Walentyna, Castel Victoria, Elliott Martin, Kogner Per, Laureys Geneviève, Luksch Roberto, Malis Josef, Popovic-Beck Maja, Ash Shifra, Delattre Olivier, Valteau-Couanet Dominique, Tweddle Deborah A, Ladenstein Ruth, Schleiermacher Gudr |
- Page last reviewed:Feb 1, 2024
- Content source:

